Academia.eduAcademia.edu
Extended Abstract Evaluation of Echinophora Tenuifolia L. Extracts on HSC-2 Cell Line † Claudia Arena 1,*, Marco Vairano 1, Marco Mascitti 2, Andrea Santarelli 2, Mario Dioguardi 1 and Khrystyna Zhurakivska 1 Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy; marcovairano@gmail.com (M.V.); mario.dioguardi@unifg.it (M.D.); khrystyna.zhurakivska@unifg.it (K.Z.) 2 Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic, 60131 Ancona, Italy; marcomascitti86@hotmail.it (M.M.); andrea.santarelli@univpm.it (A.S.) * Correspondence: claudia.arena@unifg.it; Tel.: +39-3406305228 † Presented at the XV National and III International Congress of the Italian Society of Oral Pathology and Medicine (SIPMO), Bari, Italy, 17–19 October 2019. 1 Published: 11 December 2019 Oral squamous cell carcinoma survival is still poor, although the improvement in treatments both in surgical and chemotherapy [1]. Conventional treatments are also associated with acute and chronic toxicity, which leads to a decrease of quality life [2]. Natural compounds are a promising alternative, since they can affect the different steps of tumor cell development, with poor toxic events. E. Tenuifolia L. showed promising anticancer activities in several cancer models, due to its antioxidant activity [3,4]. In order to verify its anticancer activity in a cellular model of squamous cell carcinoma, HSC-2, we performed a MTT cell proliferation assay, by adding this compound at time 0 (t0). HSC-2 were cultured in cell culture flask at 37 °C with 5% CO2 in RPMI medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin-streptomycin and 1% L-Glutammine. We used the inflorescences total extract (20 mg/mL in EtOH 70%) and we evaluated the production of formazan in order to determine the cell viability, at 24 h, 48 h and 72 h. When comparing these results, with results coming from cells in addition with ethanol only, we observed a decrease in cell viability of 40%. Future studies should deeply investigate the role of Echinophora Tenuifolia L. as possible adjuvant in cancer therapy, in order to understand its role in pathways and molecular targets. Conflicts of Interest: The authors declare no conflict of interest. References 1. 2. 3. 4. Suh, Y.; Amelio, I. Clinical update on cancer: molecular oncology of head and neck cancer. Cell Death Dis. 2014, 5, e1018. Valdez, J.A.; Brennan, M.T. Impact of Oral Cancer on Quality of Life. Dent. Clin. N. Am. 2018, 62, 143–154. Marrelli, M.; Pisani, F.; Amodeo, V.; Duez, P.; Conforti, F. Echinophora tenuifolia L. branches phytochemical profile and antiproliferative activity on human cancer cell lines. Nat. Prod. Res. 2019, 1–4, doi:10.1080/14786419.2018.1548457 Marrelli, M.; Statti, G.A.; Menichini, F.; Conforti, F. Echinophora tenuifolia L. inflorescences: phytochemistry and in vitro antioxidant and anti-inflammatory properties in LPS-stimulated RAW 264.7 macrophages. Plant Biosyst. 2017, 151, 1073–1081. © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Proceedings 2019, 35, 12; doi: 10.3390/proceedings2019035012 www.mdpi.com/journal/proceedings